Insomnia and sleep apnea in midlife women: Prevalence and consequences to health and functioning

Martica H. Hall, Christopher E. Kline, Sara Nowakowski

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Sleep disturbance is common during the menopausal transition, with numerous downstream consequences to health and functioning, including reduced quality of life, impaired mental health, and increased physical health morbidity. Insomnia affects approximately 50% of midlife women and is characterized by nocturnal symptoms of difficulties initiating or maintaining sleep (or both) and daytime symptoms that impair occupational, social, or other components of functioning. In addition, approximately 20% of midlife women develop sleep-disordered breathing during the menopausal transition. This commentary summarizes the prevalence, risk factors, and treatment options for each of these sleep disorders in midlife women, with specific focus on first-line treatments for insomnia (cognitive behavioral therapy for insomnia) and sleep-disordered breathing (continuous positive airway pressure) and unique considerations for treating sleep disorders in midlife women. Future directions are also discussed.

Original languageEnglish (US)
Article number63
JournalF1000Prime Reports
Volume7
DOIs
StatePublished - May 26 2015

Fingerprint

Sleep Apnea Syndromes
Sleep Initiation and Maintenance Disorders
Health
Sleep
Continuous Positive Airway Pressure
Cognitive Therapy
Mental Health
Quality of Life
Morbidity
Therapeutics
Sleep Wake Disorders

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Insomnia and sleep apnea in midlife women : Prevalence and consequences to health and functioning. / Hall, Martica H.; Kline, Christopher E.; Nowakowski, Sara.

In: F1000Prime Reports, Vol. 7, 63, 26.05.2015.

Research output: Contribution to journalArticle

Hall, Martica H. ; Kline, Christopher E. ; Nowakowski, Sara. / Insomnia and sleep apnea in midlife women : Prevalence and consequences to health and functioning. In: F1000Prime Reports. 2015 ; Vol. 7.
@article{f1f5b667a16646069e3e44f57feb7aff,
title = "Insomnia and sleep apnea in midlife women: Prevalence and consequences to health and functioning",
abstract = "Sleep disturbance is common during the menopausal transition, with numerous downstream consequences to health and functioning, including reduced quality of life, impaired mental health, and increased physical health morbidity. Insomnia affects approximately 50{\%} of midlife women and is characterized by nocturnal symptoms of difficulties initiating or maintaining sleep (or both) and daytime symptoms that impair occupational, social, or other components of functioning. In addition, approximately 20{\%} of midlife women develop sleep-disordered breathing during the menopausal transition. This commentary summarizes the prevalence, risk factors, and treatment options for each of these sleep disorders in midlife women, with specific focus on first-line treatments for insomnia (cognitive behavioral therapy for insomnia) and sleep-disordered breathing (continuous positive airway pressure) and unique considerations for treating sleep disorders in midlife women. Future directions are also discussed.",
author = "Hall, {Martica H.} and Kline, {Christopher E.} and Sara Nowakowski",
year = "2015",
month = "5",
day = "26",
doi = "10.12703/P7-63",
language = "English (US)",
volume = "7",
journal = "F1000Prime Reports",
issn = "2051-7599",
publisher = "Faculty of 1000 Ltd",

}

TY - JOUR

T1 - Insomnia and sleep apnea in midlife women

T2 - Prevalence and consequences to health and functioning

AU - Hall, Martica H.

AU - Kline, Christopher E.

AU - Nowakowski, Sara

PY - 2015/5/26

Y1 - 2015/5/26

N2 - Sleep disturbance is common during the menopausal transition, with numerous downstream consequences to health and functioning, including reduced quality of life, impaired mental health, and increased physical health morbidity. Insomnia affects approximately 50% of midlife women and is characterized by nocturnal symptoms of difficulties initiating or maintaining sleep (or both) and daytime symptoms that impair occupational, social, or other components of functioning. In addition, approximately 20% of midlife women develop sleep-disordered breathing during the menopausal transition. This commentary summarizes the prevalence, risk factors, and treatment options for each of these sleep disorders in midlife women, with specific focus on first-line treatments for insomnia (cognitive behavioral therapy for insomnia) and sleep-disordered breathing (continuous positive airway pressure) and unique considerations for treating sleep disorders in midlife women. Future directions are also discussed.

AB - Sleep disturbance is common during the menopausal transition, with numerous downstream consequences to health and functioning, including reduced quality of life, impaired mental health, and increased physical health morbidity. Insomnia affects approximately 50% of midlife women and is characterized by nocturnal symptoms of difficulties initiating or maintaining sleep (or both) and daytime symptoms that impair occupational, social, or other components of functioning. In addition, approximately 20% of midlife women develop sleep-disordered breathing during the menopausal transition. This commentary summarizes the prevalence, risk factors, and treatment options for each of these sleep disorders in midlife women, with specific focus on first-line treatments for insomnia (cognitive behavioral therapy for insomnia) and sleep-disordered breathing (continuous positive airway pressure) and unique considerations for treating sleep disorders in midlife women. Future directions are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=84931264105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931264105&partnerID=8YFLogxK

U2 - 10.12703/P7-63

DO - 10.12703/P7-63

M3 - Article

AN - SCOPUS:84931264105

VL - 7

JO - F1000Prime Reports

JF - F1000Prime Reports

SN - 2051-7599

M1 - 63

ER -